These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2956854)

  • 61. [Controlled permanent electrocardiostimulation].
    Bredikis IuIu; Drogaĭtsev AD
    Kardiologiia; 1982 May; 22(5):114-7. PubMed ID: 7098270
    [No Abstract]   [Full Text] [Related]  

  • 62. [Complications of endocardial electric stimulation].
    Gusak VK; Dziugan' SA; Kuznetsov AS; Bassov OI; Doviner AD; Finchenko VF
    Klin Khir (1962); 1990; (10):22-5. PubMed ID: 2280520
    [TBL] [Abstract][Full Text] [Related]  

  • 63. VVI pacemaker ventricular undersensing.
    Johnson CD
    Bol Asoc Med P R; 1986 Jan; 78(1):21-5. PubMed ID: 3456750
    [No Abstract]   [Full Text] [Related]  

  • 64. Case 1-1982: Atrioventricular heart block.
    Friedman HS
    N Engl J Med; 1982 Jun; 306(23):1429. PubMed ID: 7078589
    [No Abstract]   [Full Text] [Related]  

  • 65. [Experience with the implantation of sensory multiple programmable pacemakers of the Siemens firm].
    Zhdanov AM; Gukov AO; Termosesov SA
    Ter Arkh; 1994; 66(5):66-9. PubMed ID: 7940344
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Common indications of permanent pacemaker insertion.
    Ahmed SM; Ansari MJ
    Compr Ther; 2008; 34(1):24-7. PubMed ID: 18681108
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Atrial pacing lead: steroid-eluting and nonsteroid-eluting.
    Hua W; Mond H
    Chin Med J (Engl); 1998 May; 111(5):476-7. PubMed ID: 10374363
    [No Abstract]   [Full Text] [Related]  

  • 68. Cardiac pacemakers: current concepts.
    Haider R; Meyer JF; Rasul AM
    Am Fam Physician; 1984 May; 29(5):223-8. PubMed ID: 6731240
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The chronotropic response of the sinus node to exercise: a new method of analysis and a study of pacemaker patients.
    Crook B; Nijhof P; van der Kemp P; Jennison C
    Eur Heart J; 1995 Jul; 16(7):993-8. PubMed ID: 7498217
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Screening results used to assess the prevalence of haemochromatosis in a Swedish male pacemaker-treated population.
    De Marchi G; Pizzetti F; Guala A; Ghini T
    Eur Heart J; 1992 Sep; 13(9):1299-300. PubMed ID: 1396845
    [No Abstract]   [Full Text] [Related]  

  • 71. Atrial demand pacemakers in sick sinus syndrome: an efficient and reliable approach in selected patients.
    Liang KW; Lee WL; Hsueh CW; Chen YT; Ting CT
    J Chin Med Assoc; 2003 Dec; 66(12):709-14. PubMed ID: 15015819
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sick sinus syndrome and diffuse impairment of the conduction system in a child: successful pacing with a steroid eluting endocardial pacing lead.
    Capucci A; Boriani G; Galli R; Picchio FM; Pierangeli A; Magnani B
    Pediatr Cardiol; 1992 Jan; 13(1):44-7. PubMed ID: 1736268
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognosis in cardiac pacing. A comparison between patients with atrioventricular block and sick sinus syndrome.
    Otterstad JE; Selmer R; Strøm O
    Acta Med Scand; 1981; 210(1-2):47-52. PubMed ID: 7293827
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [A clinical analysis of atrial-ventricular sequential pacing].
    Wang F; Sun R; Yu P
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Feb; 20(1):19-21, 69. PubMed ID: 1396088
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of cilostazol on the ventricular escape rate and neurohumoral factors in patients with third-degree atrioventricular block.
    Kodama-Takahashi K; Kurata A; Ohshima K; Yamamoto K; Uemura S; Watanabe S; Iwata T
    Chest; 2003 Apr; 123(4):1161-9. PubMed ID: 12684307
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Concerns about sources of electromagnetic interference in patients with pacemakers.
    Sakakibara Y; Mitsui T
    Jpn Heart J; 1999 Nov; 40(6):737-43. PubMed ID: 10737557
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Atrial natriuretic peptide with artificial pacemakers.
    Nakaoka H; Kitahara Y; Imataka K; Fujii J; Ishibashi M; Yamaji T
    Am J Cardiol; 1987 Aug; 60(4):384-5. PubMed ID: 2956854
    [No Abstract]   [Full Text] [Related]  

  • 78. [The effect of ventricular pacing on plasma atrial natriuretic factor levels and its clinical significance].
    Wei M
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Oct; 21(5):292-5, 316. PubMed ID: 8200313
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Plasma natriuretic peptide levels and daily physical activity in patients with pacemaker implantation.
    Wu X; Seino Y; Ogura H; Fukuma N; Katoh T; Takano T
    Jpn Heart J; 2001 Jul; 42(4):471-82. PubMed ID: 11693283
    [TBL] [Abstract][Full Text] [Related]  

  • 80. ANP concentrations during interchanging DDD-VVI pacing modes in patients with retrograde ventriculoatrial conduction.
    Papadopoulos CL; Kokkas BA; Sakadamis GC; Kanonidis IE; Kotridis PS; Karamouzis MI; Koukoulekidis GN; Nikolaidis NK; Missopoulou-Kokka A; Gitsios CT
    Acta Cardiol; 1997; 52(1):37-47. PubMed ID: 9139520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.